IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia

Background and relationale for the study. Genome-wide association studies have identified host genetic variation to be critical for spontaneous clearance and treatment response in patients infected with hepatitis C virus. Recently, the role of the IFNL3 polymorphisms in influencing the spontaneous c...

Full description

Bibliographic Details
Main Authors:	Raffaella Origa, Giuseppe Marceddu, Fabrice Danjou, Luciana Perseu, Stefania Satta, Franca Rosa Demartis, Antonio Piga, Filomena Longo, Maria-Eliana Lai, Stefania Vacquer, Renzo Galanello
Format:	Article
Language:	English
Published:	Elsevier 2015-05-01
Series:	Annals of Hepatology
Subjects:	Transfusion-borne infections Virus C IL28B Viral clearance Viral persistence
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119312797

Similar Items

Beta-thalassemia
by: Origa Raffaella, et al.
Published: (2010-05-01)

Phenotype-genotype correlation in β-thalassemia
by: R. Galanello, et al.
Published: (2011-12-01)

Frequency of Hepatitis B in Thalassemia Major Patients
by: Akber Hussain, et al.
Published: (2023-04-01)

An updated analysis of viral clearance unit operations for biotechnology manufacturing
by: Opeyemi O. Ajayi, et al.
Published: (2022-01-01)

Recurrence of COVID-19 related symptoms and viral detection in patient discharged after complete recovery and test negativization
by: Chiara Vassallo, et al.
Published: (2021-01-01)

Factors Associated with Prolonged RT-PCR SARS-CoV-2 Positive Testing in Patients with Mild and Moderate Forms of COVID-19: A Retrospective Study
by: Nicoleta Stefania Motoc, et al.
Published: (2022-05-01)

Relationship between glucocorticoids and viral load during the Omicron wave in mainland China
by: Guangxu Bai, et al.
Published: (2023-11-01)

Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending
by: Raffaella Origa
Published: (2023-05-01)

The Incidence of Transfusion Hepatitis in Donetsk Region in 2013
by: O.N. Domashenko, et al.
Published: (2014-09-01)

Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients
by: Serkan Ocal, et al.
Published: (2014-01-01)

Effects of dexamethasone use on viral clearance among patients with COVID-19: a multicenter cohort study
by: Shu-Min Lin, et al.
Published: (2023-03-01)

Glucocorticoid therapy does not delay viral clearance in COVID-19 patients
by: Jingjing Ji, et al.
Published: (2020-09-01)

Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients
by: Daniel Valle-Millares, et al.
Published: (2021-11-01)

Evaluating the viral clearance ability of continuous monoclonal antibody purification steps, in order to inactivate and/or remove four model viruses
by: Seyed Mohammad Rasouli-Nejad Mousavi, et al.
Published: (2023-10-01)

SARS-CoV-2 viral clearance and viral load kinetics in young children (1–6 years) compared to adults: Results of a longitudinal study in Germany
by: Anna Sandoni, et al.
Published: (2022-11-01)

Does COVID-19 Vaccination Protect Contact Persons? A Systematic Review
by: Günter Kampf
Published: (2024-01-01)

Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods
by: Denise Utami Putri, et al.
Published: (2021-03-01)

Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients
by: Camila Fernanda da Silveira Alves, et al.

Chronic HCV Infection Is Associated with Overexpression of Human Endogenous Retroviruses that Persists after Drug-Induced Viral Clearance
by: Pier-Angelo Tovo, et al.
Published: (2020-06-01)

CD4 count, viral load and parasite density of HIV positive individuals undergoing malaria treatment with dihydroartemisinin in Benin City, Edo state, Nigeria
by: Y.M. Tatfeng, J.C. Ihongbe, M. Okodua, F. Oviasogie, J. Isibor, S. Tchougang, E. Tambo , T. Otegbeye
Published: (2007-06-01)

Urine Spot Protein Creatinine Ratio as a Predictor of Disease Severity and Adverse Outcome in Children with Dengue: A Cross-sectional Study
by: Edinta Joseph, et al.
Published: (2022-09-01)

Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis
by: Jianbo Li, et al.
Published: (2021-10-01)

Transfusion transmitted diseases in perioperative and intensive care settings
by: Rekha Das, et al.
Published: (2014-01-01)

Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
by: Annalisa Mondi, et al.
Published: (2021-04-01)

The Dietary Intake of Carrot-Derived Rhamnogalacturonan-I Accelerates and Augments the Innate Immune and Anti-Viral Interferon Response to Rhinovirus Infection and Reduces Duration and Severity of Symptoms in Humans in a Randomized Trial
by: René Lutter, et al.
Published: (2021-12-01)

Treatment of Sindbis Virus-Infected Neurons with Antibody to E2 Alters Synthesis of Complete and nsP1-Expressing Defective Viral RNAs
by: Jane X. Yeh, et al.
Published: (2022-10-01)

Gene Therapy for Acute Respiratory Distress Syndrome
by: Jing Liu, et al.
Published: (2022-01-01)

HCV Defective Genomes Promote Persistent Infection by Modulating the Viral Life Cycle
by: Eirini Karamichali, et al.
Published: (2018-12-01)

Risk factors associated with prolonged viral clearance in patients with a refractory course of COVID-19: a retrospective study
by: Weitao Zhuang, et al.
Published: (2021-11-01)

Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance
by: Mihaela Zlei, et al.
Published: (2022-09-01)

Treatment options of the nasal cavity and paranasal sinuses diseases
by: S. A. Karpishchenko, et al.
Published: (2019-11-01)

Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
by: Spagnuolo V, et al.
Published: (2022-10-01)

Adaptive Immunity to Hepatitis C Virus
by: Françoise Stoll-Keller, et al.
Published: (2009-09-01)

Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin
by: Guillermo Cabrera Álvarez, et al.
Published: (2011-10-01)

Interferon-Gamma Modulation of the Local T Cell Response to Alphavirus Encephalomyelitis
by: Victoria K. Baxter, et al.
Published: (2020-01-01)

Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines
by: Mina eJohn, et al.
Published: (2014-10-01)

The Role of RASs /RVs in the Current Management of HCV
by: Konstantinos Malandris, et al.
Published: (2021-10-01)

Correlation Study Between HCV Genotypes Distribution Pattern and Viral Load in a Tertiary Care Hospital in Kolkata, India
by: Debojyoti Bhattacharjee, et al.
Published: (2015-05-01)

Effect of methylprednisolone therapy on hospital stay and viral clearance in patients with moderate COVID-19
by: Xiaoyan Li, et al.
Published: (2022-12-01)

Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model
by: Sarah A. Brendle, et al.
Published: (2023-12-01)